廣澤國際發展(00989.HK):近期控股股東家譯出售公司股份合共1.43億股
格隆匯 12 月 2日丨廣澤國際發展(00989.HK)公告,已獲公司控股股東家譯投資有限公司("家譯")及美成集團有限公司告知,在2020年11月30日及2020年12月2日,家譯已在聯交所向四名購買者出售公司股份合共1.43億股股份,約佔2.39%公司的已發行股。緊接有關出售事項完成前,家譯及美成持有合共33.02億股權益,佔公司已發行股約55.29%。
在2020年12月2日,公司接獲家譯一份轉換股份通知書,以根據可換股優先股的條款及條件,將1億股可換股優先股轉換為1億股轉換股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.